Idecabtagene vicleucel

Idecabtagene vicleucel, known by its brand name Abecma, is a specific treatment for multiple myeloma that uses your own cells. First, a process called leukapheresis collects certain white blood cells from your body. These cells are then modified in a laboratory to help them specifically target multiple myeloma cells. Finally, these specially prepared cells are given back to you as a single infusion through a vein. This topic provides details about how Abecma works, what is involved in the process, and what you might expect during your treatment journey.